Outside the Macclesfield factory of AstraZeneca.
Christopher Furlong | Getty Images News | Getty Images
British pharmaceutical giant AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing.
The new hub is expected to take AstraZeneca’s Beijing workforce to around 1,700 employees.
Don’t miss AstraZeneca’s CEO Pascal Soriot interview live on CNBC International at 11:30 a.m. London time / 7:30 a.m. ET.
This breaking news story is being updated.
